Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,985 active trials259 approved drugs4,032 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,916 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02044861 | Phase 1 Safety Study of ACT-PFK-158, 2HCl in Patients With Advanced Solid Malignancies | unknown | Phase 1 | 56 | Advanced Cancer TherapeuticsINDUSTRY | 1 | Jun 23, 2015 | clinicaltrials |
| NCT02469883 | A Study of Sinotecean on Tolerance and Pharmacokinetics | unknown | Phase 1 | 20 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Jun 12, 2015 | clinicaltrials |
| NCT00524784 | Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD | unknown | Phase 1 / Phase 2 | 12 | Hadassah Medical OrganizationOTHER | 1 | Jun 11, 2015 | clinicaltrials |
| NCT02467647 | The Effects of Huang-Lian-Jie-Du-Tang（HLJDT) on the Survival of Patients With Multiple Myeloma in Maintain Therapy(HLJDT-2016) | unknown | Phase 1 | 500 | Wuhan UniversityOTHER | 1 | Jun 10, 2015 | clinicaltrials |
| NCT02278458 | Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer | unknown | Phase 1 | 24 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | May 22, 2015 | clinicaltrials |
| NCT01764087 | A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors | unknown | Phase 1 / Phase 2 | 60 | Hanmi Pharmaceutical Company LimitedINDUSTRY | 1 | May 18, 2015 | clinicaltrials |
| NCT02431403 | ESHAP-Imatinib for Refractory/Relapsed Non-Hodgkin's Lymphoma | unknown | Phase 1 / Phase 2 | 94 | Pusan National University HospitalOTHER | 1 | May 5, 2015 | clinicaltrials |
| NCT01914263 | Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection | unknown | Phase 1 | 40 | Alliancells-PuRui Biocience Co., Ltd.INDUSTRY | 1 | Apr 16, 2015 | clinicaltrials |
| NCT01772732 | Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of Simotinib Hydrochloride in Patients With Advanced NSCLC | unknown | Phase 1 | 30 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 9, 2015 | clinicaltrials |
| NCT02211443 | Safety, Tolerability and Pharmacokinetics of Recombinant Anti-epidermal Growth Factor Receptor(EGFR) Monoclonal Antibody in Patients With Metastatic Colorectal Cancer | unknown | Phase 1 | 21 | Sinocelltech Ltd.INDUSTRY | 0 | Apr 9, 2015 | clinicaltrials |
| NCT02065960 | Feasibility Study of Stereotactic Body Radiotherapy for Early Breast Cancer(ARTEMIS) | unknown | Phase 1 | 32 | Juravinski Cancer CenterOTHER | 1 | Mar 31, 2015 | clinicaltrials |
| NCT01847118 | A Phase Ia, Dose Escalation Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection in Patients With Advanced or Metastatic Solid Tumors | unknown | Phase 1 | 31 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Mar 24, 2015 | clinicaltrials |
| NCT02395679 | Dendritic Cells Loaded With Allogeneous Cell Lysate in Mesothelioma Patients(MesoCancerVa) | unknown | Phase 1 | 9 | Erasmus Medical CenterOTHER | 1 | Mar 23, 2015 | clinicaltrials |
| NCT02066870 | Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI | unknown | Phase 1 | 9 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Mar 13, 2015 | clinicaltrials |
| NCT01368757 | Lenalidomide in Patients With Chronic Myelomonocytic Leukemia | unknown | Phase 1 / Phase 2 | 30 | Arbeitsgemeinschaft medikamentoese TumortherapieOTHER | 1 | Mar 9, 2015 | clinicaltrials |
| NCT01298934 | LBH589 (Panobinostat) for the Treatment of Myelofibrosis | unknown | Phase 1 / Phase 2 | 22 | Ronald HoffmanOTHER | 1 | Mar 6, 2015 | clinicaltrials |
| NCT02378389 | Study Evaluating Pyrotinib/Pyrotinib in Combination With Docetaxel in Patients With HER2+ Advanced Gastric Cancer | unknown | Phase 1 | 28 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Mar 4, 2015 | clinicaltrials |
| NCT02213419 | Endoscopic Ultrasonography-guided Double Ethanol Lavage for Pancreatic Cysts: a Prospective Cohort Study | unknown | Phase 1 | 40 | Samsung Medical CenterOTHER | 1 | Feb 12, 2015 | clinicaltrials |
| NCT00818831 | A Study of QBI-139 in Subjects With Advanced Solid Tumors | unknown | Phase 1 | 30 | Quintessence Biosciences, Inc.INDUSTRY | 1 | Jan 28, 2015 | clinicaltrials |
| NCT01715168 | A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer | unknown | Phase 1 | 40 | Azaya Therapeutics, Inc.INDUSTRY | 2 | Jan 15, 2015 | clinicaltrials |
| NCT02331693 | CAR T Cells in Treating Patients With Malignant Gliomas Overexpressing EGFR | unknown | Phase 1 | 10 | RenJi HospitalOTHER | 1 | Jan 6, 2015 | clinicaltrials |
| NCT02314884 | Phase I Trial to Investigate Cafusertib Hydrochloride Monotherapy in Chinese Patients With Advanced Solid Tumours | unknown | Phase 1 | 40 | Jiangsu Hansoh Pharmaceutical Co., Ltd.INDUSTRY | 1 | Dec 12, 2014 | clinicaltrials |
| NCT02277158 | Phase I Study of CCRT as Adjuvant Treatment for Stage II/III Operable Rectal Cancer. | unknown | Phase 1 | 18 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT00668421 | CEP-701 (Lestaurtinib) in Myelofibrosis | unknown | Phase 1 / Phase 2 | 60 | Ronald HoffmanOTHER | 1 | Nov 26, 2014 | clinicaltrials |
| NCT01462903 | A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors | unknown | Phase 1 | 20 | Sun Yat-sen UniversityOTHER | 1 | Nov 24, 2014 | clinicaltrials |
| NCT02298608 | Efficacy and Safety of IRE for RMs | unknown | Phase 1 / Phase 2 | 10 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Nov 24, 2014 | clinicaltrials |
| NCT01967407 | IReversible Electroporation of Kidney Tumors Before Partial Nephrectomy.(IRENE) | unknown | Phase 1 / Phase 2 | 20 | University of MagdeburgOTHER | 1 | Nov 19, 2014 | clinicaltrials |
| NCT02283502 | Clinical Test of the MRgHIFU System on Uterine Fibroids(MRgHIFU) | unknown | Phase 1 | 20 | Chin-Jung WangOTHER | 1 | Nov 5, 2014 | clinicaltrials |
| NCT02274584 | CAR T Cells Targeting CD30 Positive Lymphomas (4SCAR30273) | unknown | Phase 1 / Phase 2 | 20 | Peking UniversityOTHER | 2 | Oct 24, 2014 | clinicaltrials |
| NCT02247609 | Evaluation of 4th Generation Safety-designed CAR T Cells Targeting High-risk and Refractory B Cell Lymphomas(4SCAR19273) | unknown | Phase 1 / Phase 2 | 20 | Peking UniversityOTHER | 1 | Oct 20, 2014 | clinicaltrials |
| NCT01919866 | Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells | unknown | Phase 1 / Phase 2 | 120 | University Children's Hospital TuebingenOTHER | 2 | Oct 8, 2014 | clinicaltrials |
| NCT01426841 | Pilot Project of Adaptive Thoracic Radiotherapy for Small Cell Lung Cancer | unknown | Phase 1 | 10 | AHS Cancer Control AlbertaOTHER | 1 | Oct 2, 2014 | clinicaltrials |
| NCT01157052 | Oxaliplatin Pharmacokinetics With and Without Ca2+/MG2+ Infusion in Colorectal Cancer Patients | unknown | Phase 1 | 15 | AHS Cancer Control AlbertaOTHER | 1 | Oct 1, 2014 | clinicaltrials |
| NCT01611961 | Docetaxel Lipid Microsphere (DT-LM) for Injection in Chemotherapy Patients | unknown | Phase 1 | 35 | Shenyang Pharmaceutical UniversityOTHER | 1 | Sep 30, 2014 | clinicaltrials |
| NCT02248402 | Autologous Dendritic Cell Therapy in Patients With Relapsed or Refractory Multiple Myeloma(Vax-DC/MM) | unknown | Phase 1 / Phase 2 | 15 | Chonnam National University HospitalOTHER | 1 | Sep 25, 2014 | clinicaltrials |
| NCT00688116 | Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors | unknown | Phase 1 | 45 | Synta Pharmaceuticals Corp.INDUSTRY | 1 | Sep 18, 2014 | clinicaltrials |
| NCT01435720 | Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) | unknown | Phase 1 / Phase 2 | 15 | Senesco Technologies, Inc.INDUSTRY | 2 | Sep 11, 2014 | clinicaltrials |
| NCT02233725 | MRI / Ultrasound Fusion With Contrast-Enhanced Ultrasound Guidance | unknown | Phase 1 | 50 | University of British ColumbiaOTHER | 1 | Sep 8, 2014 | clinicaltrials |
| NCT01159405 | The Study of Biodistribution and Dosimetry of 99mTc-Glycopeptide(99mTc-GP) in Patients With Breast Cancer | unknown | Phase 1 | 9 | SeeCure LLCINDUSTRY | 1 | Jul 30, 2014 | clinicaltrials |
| NCT01279707 | Monoclonal Antibodies in Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) (MARALL)(MARALL) | unknown | Phase 1 / Phase 2 | 55 | Queen Mary University of LondonOTHER | 1 | Jul 14, 2014 | clinicaltrials |
| NCT01721941 | TH-302 Plus Doxorubicin Delivered by Trans-Arterial Chemoembolization (TACE) in Patients With Hepatocellular Carcinoma | unknown | Phase 1 | 20 | Scripps Clinic Cancer CenterOTHER | 1 | Jul 4, 2014 | clinicaltrials |
| NCT02178280 | Safety Study of Liver Transplantation for Hilar Cholangiocarcinoma | unknown | Phase 1 / Phase 2 | 60 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Jun 30, 2014 | clinicaltrials |
| NCT01354457 | Safety and Efficacy of Radio-immunotherapy (RIT) for Patients With Relapse or Refractory Acute Lymphoblastic Leukaemia (ALL) B CD22+(RIT 90YEpra) | unknown | Phase 1 / Phase 2 | 21 | Nantes University HospitalOTHER | 1 | Jun 25, 2014 | clinicaltrials |
| NCT02169388 | Intestinal Microflora in Colorectal Cancer (CRC) After Chemotherapy | unknown | Phase 1 | 30 | Shandong UniversityOTHER | 1 | Jun 25, 2014 | clinicaltrials |
| NCT00004207 | Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer | unknown | Phase 1 | — | University of LeicesterOTHER | 1 | Jun 24, 2014 | clinicaltrials |
| NCT00973869 | Curcumin in Preventing Colorectal Cancer in Patients Undergoing Colorectal Endoscopy or Colorectal Surgery | unknown | Phase 1 | 30 | University of LeicesterOTHER | 1 | Jun 24, 2014 | clinicaltrials |
| NCT02154451 | Transient Infrared Imaging for Early Detection of Skin Cancer | unknown | Phase 1 / Phase 2 | 400 | Skinfrared LLCOTHER | 1 | Jun 3, 2014 | clinicaltrials |
| NCT02140606 | Phase I Trial to Investigate Cafusertib Hydrochloride in Combination With Low Dose Cytarabine in Chinese Patients With Acute Myeloid Leukaemia (AML) | unknown | Phase 1 | — | Jiangsu Hansoh Pharmaceutical Co., Ltd.INDUSTRY | 1 | May 16, 2014 | clinicaltrials |
| NCT02131688 | Phase I Study of Mitoxantrone Hydrochloride Liposome Injection | unknown | Phase 1 | 30 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | May 6, 2014 | clinicaltrials |
| NCT00425425 | Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer | unknown | Phase 1 / Phase 2 | 43 | Technical University of MunichOTHER | 1 | May 1, 2014 | clinicaltrials |
Data updated 24 days agoSource updated Jun 23, 2015source: clinicaltrials